US drug maker Pfizer hinted it had "options" to raise its proposed $106 billion (£62.9 billion) offer if AstraZeneca would engage in talks, as its boss was grilled by UK lawmakers on Tuesday (May 13) about his commitment to British research spending and jobs.
Pfizer CEO Won't Commit to Specific Research Spend
- By Adam Justice
